Oscar Health (OSCR) Cash & Current Investments (2020 - 2026)

Oscar Health's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $6.8 billion for Q1 2026.

• Quarterly Cash & Current Investments rose 127.57% year-over-year to $6.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 billion (up 127.57% YoY) and the FY2025 annual result came in at $4.0 billion, up 85.47% from the prior year.
• Cash & Current Investments was $6.8 billion for Q1 2026 at Oscar Health, up from $4.0 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $6.8 billion in Q1 2026 and bottomed at $1.7 billion in Q3 2024.
• A 5-year average of $3.2 billion and a median of $3.0 billion in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments slumped 30.04% — and 2026, when it soared 127.57%.
• Oscar Health's Cash & Current Investments stood at $3.0 billion in 2022, then slipped by 13.39% to $2.6 billion in 2023, then fell by 15.96% to $2.2 billion in 2024, then surged by 85.47% to $4.0 billion in 2025, then soared by 70.39% to $6.8 billion in 2026.
• Business Quant data shows OSCR's Cash & Current Investments at $6.8 billion in Q1 2026, $4.0 billion in Q4 2025, and $3.0 billion in Q3 2025.